SE9303744D0 - Pharmaceutical emulsion - Google Patents

Pharmaceutical emulsion

Info

Publication number
SE9303744D0
SE9303744D0 SE9303744A SE9303744A SE9303744D0 SE 9303744 D0 SE9303744 D0 SE 9303744D0 SE 9303744 A SE9303744 A SE 9303744A SE 9303744 A SE9303744 A SE 9303744A SE 9303744 D0 SE9303744 D0 SE 9303744D0
Authority
SE
Sweden
Prior art keywords
pct
pharmaceutical emulsion
date
sec
pub
Prior art date
Application number
SE9303744A
Other languages
English (en)
Swedish (sv)
Inventor
Kjell Hjalmar Andersson
Eva Kristina Byroed
Anna-Carin Hansson
Margareta Nordlander
Rolf Christer Westerlund
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9303744A priority Critical patent/SE9303744D0/xx
Publication of SE9303744D0 publication Critical patent/SE9303744D0/xx
Priority to ZA948180A priority patent/ZA948180B/xx
Priority to IL11134594A priority patent/IL111345A/xx
Priority to IS4224A priority patent/IS2036B/is
Priority to EP95900965A priority patent/EP0727997B1/de
Priority to UA96051803A priority patent/UA40633C2/uk
Priority to HU9601268A priority patent/HU223142B1/hu
Priority to PCT/SE1994/001032 priority patent/WO1995013066A1/en
Priority to US08/364,953 priority patent/US5739152A/en
Priority to CZ19961338A priority patent/CZ290772B6/cs
Priority to EE9600052A priority patent/EE03223B1/xx
Priority to KR1019960702485A priority patent/KR100345627B1/ko
Priority to CN94194111A priority patent/CN1072934C/zh
Priority to AT95900965T priority patent/ATE213158T1/de
Priority to DK95900965T priority patent/DK0727997T3/da
Priority to ES95900965T priority patent/ES2172572T3/es
Priority to PL94314263A priority patent/PL181462B1/pl
Priority to NZ276197A priority patent/NZ276197A/en
Priority to AU10371/95A priority patent/AU678650B2/en
Priority to JP51375695A priority patent/JP3759951B2/ja
Priority to PT95900965T priority patent/PT727997E/pt
Priority to HK98114639.1A priority patent/HK1013261B/en
Priority to CA002176360A priority patent/CA2176360C/en
Priority to RU96112112A priority patent/RU2144358C1/ru
Priority to SK597-96A priority patent/SK283271B6/sk
Priority to DE69429871T priority patent/DE69429871T2/de
Priority to EG71094A priority patent/EG20764A/xx
Priority to MYPI94003029A priority patent/MY121201A/en
Priority to SA94150314A priority patent/SA94150314B1/ar
Priority to NO19961898A priority patent/NO314877B1/no
Priority to FI961999A priority patent/FI116999B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SE9303744A 1993-11-12 1993-11-12 Pharmaceutical emulsion SE9303744D0 (sv)

Priority Applications (31)

Application Number Priority Date Filing Date Title
SE9303744A SE9303744D0 (sv) 1993-11-12 1993-11-12 Pharmaceutical emulsion
ZA948180A ZA948180B (en) 1993-11-12 1994-10-18 Pharmaceutical emulsion
IL11134594A IL111345A (en) 1993-11-12 1994-10-20 Pharmaceutical emulsion comprising short acting calcium antagonist dihydropyridines
IS4224A IS2036B (is) 1993-11-12 1994-10-21 Lyfjablanda á formi dropalausnar sem inniheldur skammvirkt kalsíummótlyf af tvíhýdrópýridíngerð semvinna gegn háþrýstingi
DE69429871T DE69429871T2 (de) 1993-11-12 1994-11-03 Pharmazeutische emulsion
DK95900965T DK0727997T3 (da) 1993-11-12 1994-11-03 Farmaceutisk emulsion
NZ276197A NZ276197A (en) 1993-11-12 1994-11-03 Pharmaceutical emulsion of a 4-phenyl substituted dihydropyridine 3,5-dicarboxylic acid ester derivative
HU9601268A HU223142B1 (hu) 1993-11-12 1994-11-03 Rövid hatóidejű dihidro-piridin típusú vérnyomáscsökkentőt tartalmazó gyógyszerészeti emulzió
PCT/SE1994/001032 WO1995013066A1 (en) 1993-11-12 1994-11-03 Pharmaceutical emulsion
US08/364,953 US5739152A (en) 1993-11-12 1994-11-03 Pharmaceutical emulsion
CZ19961338A CZ290772B6 (cs) 1993-11-12 1994-11-03 Farmaceutický přípravek
EE9600052A EE03223B1 (et) 1993-11-12 1994-11-03 Kiiretoimelist dihüdropüridiinühendit sisaldav farmatseutiline emulsioon vererõhu alandamiseks ja selle valmistamise protsess
KR1019960702485A KR100345627B1 (ko) 1993-11-12 1994-11-03 단기간작용하는디히드로피리딘을함유하는약제학적유제및그의제조방법
CN94194111A CN1072934C (zh) 1993-11-12 1994-11-03 药物乳剂
AT95900965T ATE213158T1 (de) 1993-11-12 1994-11-03 Pharmazeutische emulsion
EP95900965A EP0727997B1 (de) 1993-11-12 1994-11-03 Pharmazeutische emulsion
ES95900965T ES2172572T3 (es) 1993-11-12 1994-11-03 Emulsion farmaceutica.
PL94314263A PL181462B1 (pl) 1993-11-12 1994-11-03 Preparat farmaceutyczny w postaci emulsji i sposób wytwarzania preparatu farmaceutycznego w postaci emulsji PL PL PL PL PL PL
UA96051803A UA40633C2 (uk) 1993-11-12 1994-11-03 Фармацевтичний емульсійний склад, спосіб його одержання і спосіб зниження в короткий термін тиску крові
AU10371/95A AU678650B2 (en) 1993-11-12 1994-11-03 Pharmaceutical emulsion
JP51375695A JP3759951B2 (ja) 1993-11-12 1994-11-03 薬学的乳剤
PT95900965T PT727997E (pt) 1993-11-12 1994-11-03 Emulsao farmaceutica
HK98114639.1A HK1013261B (en) 1993-11-12 1994-11-03 Pharmaceutical emulsion
CA002176360A CA2176360C (en) 1993-11-12 1994-11-03 Pharmaceutical emulsion
RU96112112A RU2144358C1 (ru) 1993-11-12 1994-11-03 Фармацевтический эмульсионный состав, способ его получения и способ понижения кровяного давления
SK597-96A SK283271B6 (sk) 1993-11-12 1994-11-03 Farmaceutický prípravok vo forme emulzie na intravenózne podanie na krátkodobé zníženie krvného tlaku a spôsob jeho výroby
EG71094A EG20764A (en) 1993-11-12 1994-11-09 Pharmaceutical emulsion
MYPI94003029A MY121201A (en) 1993-11-12 1994-11-14 Pharmaceutical emulsion.
SA94150314A SA94150314B1 (ar) 1993-11-12 1994-11-23 مستحلب دوائي pharmaceutical emulsion
NO19961898A NO314877B1 (no) 1993-11-12 1996-05-10 Farmasöytisk formulering som er en emulsjon for intravenös administrasjon,fremgangsmåte for fremstilling av emulsjonen, og anvendelse avformuleringen
FI961999A FI116999B (fi) 1993-11-12 1996-05-10 Menetelmä farmaseuttisen emulsion valmistamiseksi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9303744A SE9303744D0 (sv) 1993-11-12 1993-11-12 Pharmaceutical emulsion

Publications (1)

Publication Number Publication Date
SE9303744D0 true SE9303744D0 (sv) 1993-11-12

Family

ID=20391731

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9303744A SE9303744D0 (sv) 1993-11-12 1993-11-12 Pharmaceutical emulsion

Country Status (30)

Country Link
US (1) US5739152A (de)
EP (1) EP0727997B1 (de)
JP (1) JP3759951B2 (de)
KR (1) KR100345627B1 (de)
CN (1) CN1072934C (de)
AT (1) ATE213158T1 (de)
AU (1) AU678650B2 (de)
CA (1) CA2176360C (de)
CZ (1) CZ290772B6 (de)
DE (1) DE69429871T2 (de)
DK (1) DK0727997T3 (de)
EE (1) EE03223B1 (de)
EG (1) EG20764A (de)
ES (1) ES2172572T3 (de)
FI (1) FI116999B (de)
HU (1) HU223142B1 (de)
IL (1) IL111345A (de)
IS (1) IS2036B (de)
MY (1) MY121201A (de)
NO (1) NO314877B1 (de)
NZ (1) NZ276197A (de)
PL (1) PL181462B1 (de)
PT (1) PT727997E (de)
RU (1) RU2144358C1 (de)
SA (1) SA94150314B1 (de)
SE (1) SE9303744D0 (de)
SK (1) SK283271B6 (de)
UA (1) UA40633C2 (de)
WO (1) WO1995013066A1 (de)
ZA (1) ZA948180B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030158220A1 (en) * 1997-11-03 2003-08-21 Foss Joseph F. Use of methylnaltrexone and related compounds to treat chronic opioid use side effects
AU764001B2 (en) * 1998-05-29 2003-08-07 Skyepharma Canada Inc. Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
SE9804002D0 (sv) * 1998-11-23 1998-11-23 Astra Ab New manufacturing process
DE10036871A1 (de) 2000-07-28 2002-02-14 Pharmasol Gmbh Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
WO2002102311A2 (en) 2001-06-15 2002-12-27 Cornerstone Pharmaceuticals Nanoparticles for treating targeted tissues and cells
PL2368554T3 (pl) * 2003-04-08 2015-05-29 Progenics Pharm Inc Preparaty farmaceutyczne zawierające metylonaltrekson
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
TWI489984B (zh) 2006-08-04 2015-07-01 Wyeth Corp 用於非經腸道傳輸化合物之配方及其用途
TW200817048A (en) * 2006-09-08 2008-04-16 Wyeth Corp Dry powder compound formulations and uses thereof
JP5469593B2 (ja) 2007-03-29 2014-04-16 ワイス・エルエルシー 末梢性オピオイド受容体アンタゴニストおよびその使用
WO2008121348A2 (en) * 2007-03-29 2008-10-09 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof
MX2009010550A (es) 2007-03-29 2009-12-14 Progenics Pharm Inc Formas de cristal de bromuro de (r)-n-metilnaltrexona y uso de las mismas.
AU2008349873B2 (en) 2008-02-06 2014-02-13 Progenics Pharmaceuticals, Inc. Preparation and use of (R),(R)-2,2'-bis-methylnaltrexone
CA3108961C (en) * 2008-08-01 2024-07-02 Hospira, Inc. Pharmaceutical compositions comprising clevidipine and methods for producing low concentrations of impurities thereof
CN102186351A (zh) * 2008-08-01 2011-09-14 医药公司 药物组合物和用于稳定药物组合物的方法
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
US9034389B2 (en) * 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
JP6081058B2 (ja) * 2009-03-19 2017-02-15 第一三共株式会社 包装により安定保存された固形製剤
CN101780036B (zh) * 2010-03-30 2011-11-16 武汉武药科技有限公司 丁酸氯维地平脂微球注射液及其制备方法
WO2012051116A1 (en) 2010-10-12 2012-04-19 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
US8658676B2 (en) * 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
CN102531998A (zh) * 2010-12-09 2012-07-04 天津药物研究院 α型多晶型丁酸氯维地平结晶、其制备方法、用途和药物组合物
CN102525918A (zh) * 2010-12-30 2012-07-04 天津药物研究院 一种丁酸氯维地平的脂肪乳注射液及其制备工艺
US20120213855A1 (en) * 2011-02-17 2012-08-23 Cima Labs Inc. Dosage forms for weakly ionizable compounds
RU2623039C2 (ru) * 2011-04-01 2017-06-21 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Дигидропиридины (клевидипин) кратковременного действия для применения в восстановлении после инсульта
EP2793833B1 (de) 2011-12-20 2020-06-24 Vyome Therapeutics Limited Topische ölzusammensetzung zur behandlung von pilzinfektionen
CN110840890A (zh) 2012-10-26 2020-02-28 凯西制药公司 用于在心力衰竭中控制血压和减轻呼吸困难的方法
CN103110580B (zh) * 2013-02-20 2014-09-17 北京德立福瑞医药科技有限公司 丁酸氯维地平注射剂
CN105263525A (zh) * 2013-04-12 2016-01-20 维奥姆生物科学有限公司 抗微生物剂的组合物和制剂、它们的方法以及用于治疗微生物感染的方法
MX385243B (es) 2014-05-19 2025-03-14 The Medicines Co Nanoparticulas de clevidipina y composiciones farmaceuticas que las contienen.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3315805A1 (de) * 1983-04-30 1984-11-08 Bayer Ag, 5090 Leverkusen Wirkstoffzubereitungen
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
DE3515335C2 (de) * 1985-04-27 1995-01-26 Bayer Ag Arzneizubereitung enthaltend Dihydropyridine und Verfahren zu ihrer Herstellung
DE4217842A1 (de) * 1992-05-29 1993-12-02 Dietl Hans Calciumantagonisten enthaltende pharmazeutische Zubereitung zur intravenösen und intrakoronaren Applikation sowie Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
PL181462B1 (pl) 2001-07-31
HU9601268D0 (en) 1996-07-29
US5739152A (en) 1998-04-14
HU223142B1 (hu) 2004-03-29
JPH09505045A (ja) 1997-05-20
CZ133896A3 (en) 1996-09-11
FI961999A0 (fi) 1996-05-10
DE69429871T2 (de) 2002-08-22
UA40633C2 (uk) 2001-08-15
IL111345A0 (en) 1994-12-29
EP0727997B1 (de) 2002-02-13
MY121201A (en) 2006-01-28
CN1072934C (zh) 2001-10-17
IL111345A (en) 2000-08-31
CA2176360C (en) 2005-08-23
NO961898L (no) 1996-06-25
PL314263A1 (en) 1996-09-02
CN1136774A (zh) 1996-11-27
AU678650B2 (en) 1997-06-05
HUT74474A (en) 1996-12-30
DK0727997T3 (da) 2002-04-22
AU1037195A (en) 1995-05-29
JP3759951B2 (ja) 2006-03-29
DE69429871D1 (de) 2002-03-21
EG20764A (en) 2000-01-31
IS4224A (is) 1995-05-13
SK283271B6 (sk) 2003-04-01
SK59796A3 (en) 1996-12-04
WO1995013066A1 (en) 1995-05-18
EE03223B1 (et) 1999-10-15
ATE213158T1 (de) 2002-02-15
CA2176360A1 (en) 1995-05-18
NO961898D0 (no) 1996-05-10
ZA948180B (en) 1995-05-12
NZ276197A (en) 1997-04-24
HK1013261A1 (en) 1999-08-20
CZ290772B6 (cs) 2002-10-16
IS2036B (is) 2005-08-15
PT727997E (pt) 2002-07-31
NO314877B1 (no) 2003-06-10
ES2172572T3 (es) 2002-10-01
RU2144358C1 (ru) 2000-01-20
FI961999L (fi) 1996-05-10
FI116999B (fi) 2006-05-15
EP0727997A1 (de) 1996-08-28
SA94150314B1 (ar) 2005-06-14
KR100345627B1 (ko) 2003-03-15

Similar Documents

Publication Publication Date Title
DK0727997T3 (da) Farmaceutisk emulsion
FI970858A0 (fi) Tirilasadin parenteraalinen apuliuotinformulaatio
NO973730D0 (no) Faste virkestofftilberedninger
ATE195117T1 (de) 1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren
IT1285387B1 (it) Dispositivo e procedimento per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil.
ATE168268T1 (de) Behandlung von menschlichen retrovirus- infektionen mit 2',3'-dideoxyinosin
SE9303281D0 (sv) New formulation
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
BR9503406A (pt) Formulaçoes farmacêuticas adaptadas para inhibir para perda de osso em um ser humano
FI870589A0 (fi) Ny farmaceutisk sammansaettning och foerfarande foer framstaellning av den.
DE69525649D1 (de) Lamotrigin haltiges arzneimittel
IT1285398B1 (it) Dispositivo e procedimento per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil.
DE69420872D1 (de) Hgh enthaltende pharmazeutische zubereitungen
FI910653A0 (fi) Synteettiset reseptorianalogit
SE9303853L (sv) Användning av en inositoltrisfosfatester för beredning av läkemedel
NO964921L (no) Mellomprodukt for fremstilling av farmasöytisk aktiv forbindelse